Hem › Icke-småcellig lungcancer › Florida › Fort Lauderdale
Kliniska studier för Icke-småcellig lungcancer i Fort Lauderdale, FL
12 studier för Icke-småcellig lungcancer söker deltagare vid platser i och runt Fort Lauderdale (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekryterarFas 3
- Holy Cross Hospital, Fort Lauderdale
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
RekryterarFas 3
- The Oncology Institute of Hope and Innovation - Fort Lauderdale ( Site 0156), Fort Lauderdale
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekryterarFas 3
- Helios Clinical Research, Fort Lauderdale
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
RekryterarFas 2
- The Oncology Institute of Hope and Innovation 1, Fort Lauderdale
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
RekryterarFas 2
- Holy Cross Hospital, Fort Lauderdale
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
RekryterarFas 3
- Research Site, Fort Lauderdale
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
RekryterarFas 3
- Clinical Study Sites, Fort Lauderdale
- Clinical Study Site, Fort Lauderdale
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
RekryterarFas 3
- Holy Cross Hospital, Fort Lauderdale
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
RekryterarFas 3
- Broward Health, Fort Lauderdale
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
RekryterarFas 3
- Holy Cross Hospital, Fort Lauderdale
- The Oncology Institute of Hope and Innovation, Fort Lauderdale
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
RekryterarFas 2
- Helios Clinical Research, Fort Lauderdale
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RekryterarFas 1/2
- Holy Cross Hospital (site 213), Fort Lauderdale
Icke-småcellig lungcancer-studier i andra städer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andra studier i Fort Lauderdale
- Cancer (alla typer)7 studier
- Lungcancer7 studier
- Hjärtsvikt6 studier
- Makuladegeneration5 studier
- Äggstockscancer4 studier
- Bröstcancer4 studier
- Multipelt myelom3 studier
- Blodcancer3 studier
- Kronisk njursjukdom3 studier
- Hjärt-kärlsjukdom3 studier
- Tjocktarmscancer3 studier
- Kolorektal cancer3 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.